Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.51 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.51 |
| ▸ | PDE5A | O76074 | 16/20 | 0.50 |
| ▸ | GUCY1A1 | Q02108 | 2/20 | 0.46 |
| ▸ | GUCY1B1 | Q02153 | 2/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16457957 | 0.84 | ADORA3 (0.56) | ADORA3KCNH2PDE5A | |
| SCHEMBL6218458 | 0.81 | ADORA3 (0.61) | ADORA3KCNH2PDE5AGUCY1A1GUCY1B1 | |
| SCHEMBL12764541 | 0.79 | ADORA3 (0.61) | ADORA3KCNH2PDE5AGUCY1A1GUCY1B1 | |
| SCHEMBL18496415 | 0.78 | PDE5A (0.59) | ADORA3KCNH2PDE5A | |
| SCHEMBL175433 | 0.78 | ADORA3 (0.68) | ADORA3KCNH2PDE5AGUCY1A1GUCY1B1 | |
| SCHEMBL9913977 | 0.78 | GUCY1A1 (0.53) | ADORA3KCNH2PDE5AGUCY1A1GUCY1B1 | |
| SCHEMBL15111651 | 0.77 | PDE5A (0.55) | ADORA3KCNH2PDE5A | |
| SCHEMBL974087 | 0.77 | ADORA3 (0.56) | ADORA3KCNH2PDE5AGUCY1A1GUCY1B1 | |
| SCHEMBL15087495 | 0.77 | PDE5A (0.57) | ADORA3KCNH2PDE5A | |
| SCHEMBL29378676 | 0.77 | ADORA3 (0.56) | ADORA3KCNH2PDE5AGUCY1A1GUCY1B1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2708539-A1 | Annulated pyrimidines and triazines and their use | Bayer Intellectual Property GmbH (DE) | 2014-03-19 | — | — | EP | disclosed |
| EP-2682394-A1 | 1H-pyrazolo[3,4-b]pyridin-triazine derivatives and their use for the treatment or the prevention of cardiovascular diseases | Bayer Intellectual Property GmbH (DE) | 2014-01-08 | — | — | EP | disclosed |